Hydrogen Peroxide Patent Expiration
Hydrogen Peroxide is Used for treating raised seborrheic keratoses. It was first introduced by Aclaris Therapeutics Inc
Hydrogen Peroxide Patents
Given below is the list of patents protecting Hydrogen Peroxide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Eskata | US9675639 | Peroxide formulations and methods and applicators for using the same | Jul 04, 2035 | Aclaris |
| Eskata | US10098910 | Peroxide formulations and methods and applicators for using the same | Apr 21, 2035 | Aclaris |
| Eskata | US10493103 | Peroxide formulations and methods and applicators for using the same | Apr 21, 2035 | Aclaris |
| Eskata | US10729720 | Peroxide formulations and methods and applicators for using the same | Apr 21, 2035 | Aclaris |
| Eskata | US9980983 | Peroxide formulations and methods and applicators for using the same | Apr 21, 2035 | Aclaris |
| Eskata | US7381427 | Seborrheic keratosis treatment |
Jun 08, 2022
(Expired) | Aclaris |
About Veterinary Hydrogen Peroxide
Hydrogen Peroxide is used in a drug marketed by 1 company: Syndel Usa.
Other drugs containing Hydrogen Peroxide are: 35% perox aid .
Hydrogen Peroxide's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Hydrogen Peroxide:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Hydrogen Peroxide 40% Versus Salicylic Acid 40% for Plantar Warts | Assiut University | NA |
NOT YET RECRUITING
(Sep 1, 2026)
| PHASE3 |
| KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer | Institute of Cancer Research, United Kingdom | NA |
ACTIVE NOT RECRUITING
(Aug 1, 2026)
| PHASE2 |
| Clostridium Butyricum in Stenosing Crohn's Disease | San Giovanni Addolorata Hospital | NA |
RECRUITING
(Jul 1, 2026)
| PHASE1, PHASE2 |
| Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer | West China Hospital | NA |
NOT YET RECRUITING
(Jun 1, 2026)
| PHASE2 |
| Effects of Two Daily CHX Mouthrinses on Plaque, Gingivitis and Staining | Dental School | NA |
COMPLETED
(Apr 1, 2026)
| PHASE3 |
| Bioadhesive Film of Acmella Oleracea (Jambu) in the Reduction of Post-bleaching Dental Sensitivity Caused by Bleaching With 35% Hydrogen Peroxide. | Universidade Federal do Para | NA |
COMPLETED
(Mar 1, 2026)
| PHASE3 |